Patel’s allies “peddling myths” on civil service pay, says FDA
The FDA has accused allies of International Development Secretary Priti Patel of “peddling myths” on civil service pay after a report in the Daily Telegraph claimed she believed salaries were “too high” and needed to be “restrained”.
The Telegraph said “sources close to” Patel had described senior civil service salaries as “crazy” and claimed they were “way out of line with public opinion”.
FDA General Secretary Dave Penman condemned allies of Patel for taking the “easy option of briefing against those who can’t answer back” and defended members who, due to their “sense of public duty”, will continue to do their best to serve the public despite such attacks.
Penman said: “This latest misrepresentation of public sector pay from ‘sources close to’ the International Development Secretary demonstrates a blatant disregard for the Government’s own research.
“The source peddles tired myths about public sector perks and claims that pay is ‘out of step with many other comparable external roles’ – despite the Government’s figures showing that Directors General earn 62% less than their private sector counterparts.”
The FDA General Secretary said he took particular exception to the “dismissive” claim that civil servants would accept pay cuts because they are not going to “walk into better paid jobs in the real world”.
“The Government’s own analysis shows that many of them are now choosing to do just that,” Penman added. “More than half of all Senior Civil Servants who quit last year cited pay as a significant reason for their exit.”
Related News
-
Why we need an independent pay review body for delegated grades
Assistant General Secretary Lauren Crowley outlines the FDA’s response to this week’s pay announcements and shares the FDA’s long-term plans for civil service pay.
-
A different approach
With civil service pay largely unchanged for the last 30 years, Dave Penman outlines why the next government should make long-term reform an early priority.
-
FDA calls for substantial reform of NCA pay structure
In its evidence to the National Crime Agency Pay Review Body the FDA argues for urgent reform of the NCA pay structure.